Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 20,108 shares at $14.98 ($301K) on 2020-09-08, disclosed to the SEC on 2020-09-10.
Open-market sale of $301k KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.98 | 10,054 | $151K | 50.0% |
| 2 | $14.98 | 10,054 | $151K | 50.0% |
| Total | $14.98 avg | 20,108 | $301K | 100% |
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |
| KPTI | SELL | 2020-03-04 | $672K | — | Filing → |